Literature DB >> 3608196

Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assay.

H Anai, Y Maehara, H Kusumoto, K Sugimachi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608196     DOI: 10.1016/0009-8981(87)90204-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  6 in total

1.  In vitro evaluation of a novel chemotherapeutic agent, Adozelesin, in gynecologic-cancer cell lines.

Authors:  H N Nguyen; B U Sevin; H Averette; J Perras; R Hightower; R Ramos; D Donato; M Penalver
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays.

Authors:  Michael E Sughrue; Martin J Rutkowski; Ari J Kane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-09-09       Impact factor: 1.961

3.  5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.

Authors:  Y Maehara; Y Sakaguchi; I Takahashi; M Yoshida; H Kusumoto; H Masuda; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Assessment of effect of photosensitizers on cytotoxicity of photodynamic therapy in human breast cancer cell cultures.

Authors:  O R Koechli; G N Schaer; V Schenk; U Haller; H Walt
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

5.  In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma--relationship to DNA content.

Authors:  A Saito; D Korenaga; Y Maehara; H Baba; T Okamura; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay.

Authors:  O R Koechli; B U Sevin; J P Perras; T C Chou; R Angioli; A Steren; M Untch; H E Averette
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.